Effect of Food on the Pharmacokinetics of AQW051 in Japanese Healthy Male Subjects
NCT00409500 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 54
Last updated 2007-06-22
Summary
This study will evaluate safety, tolerability and pharmacokinetics of individual oral doses of AQW051 in Japanese healthy male subjects, and will also evaluate the effect of food on the pharmacokinetics of AQW051.
Conditions
- Healthy
Interventions
- DRUG
-
AQW051
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Japan · Investigator site
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 45 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-10-31
Countries
- Japan
Study Locations
More Related Trials
-
Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects
NCT01475981 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Japanese Participants.
NCT04958291 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of JNJ-42165279 in Healthy Japanese Male Participants
NCT03564379 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Different Doses of BI 690517 Are Taken Up in the Body and How Well They Are Tolerated
NCT03608072 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD5055 in Japanese and Chinese Healthy Volunteers..
NCT05955183 ·Status: COMPLETED ·Phase: PHASE1
-
Japanese Single and Multiple Ascending Dose (JSMAD), Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) Study of AZD5069
NCT01100047 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics of AEB071
NCT00409929 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Dose Study to Explore the Safety and Pharmacokinetics of JNJ-39758979 In Healthy Male Volunteers of Either Caucasian or Japanese Descent
NCT01081821 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JNJ-39439335 in Healthy Japanese and Caucasian Adult Male Participants
NCT01631487 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Pharmacokinetics, Safety, and QTc Effect of AG-348 in Healthy Subjects of Japanese Origin and Non-Asian Origin
NCT03250598 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Immunogenicity of QGE031 in Japanese Atopic Male Subjects
NCT01596712 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety, Tolerability and PK Following Single and Multiple Ascending Doses of AZD7295 in Japanese
NCT00818129 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men
NCT03400488 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Different Doses of BI 1569912 Are Taken up by the Body and How Well They Are Tolerated
NCT04958252 ·Status: COMPLETED ·Phase: PHASE1
-
Multiple Oral Doses Of PH-797804 In Healthy Japanese Adult Subjects
NCT01217918 ·Status: COMPLETED ·Phase: PHASE1
-
The Safety, Tolerability And Pharmacokinetics Of Single Ascending Doses And The Effect Of Food On Oral WCK 4873 In Healthy Adult Volunteers
NCT03926962 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Investigate Safety and Tolerability Single Ascending Doses of AZD4017.
NCT00799747 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Doses With Titration of TAK-935 in Healthy Japanese Participants
NCT04461483 ·Status: COMPLETED ·Phase: PHASE1
-
Pharmacokinetic/Pharmacodynamic Characteristics and Safety/Tolerability of MT921 in Healthy Subjects
NCT03905291 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test the Safety and Tolerability and Pharmacokinetics of Single Doses of UCB0107 in Healthy Japanese Subjects
NCT03605082 ·Status: COMPLETED ·Phase: PHASE1
-
JNJ-41443532 Sex, Race, and Age Pharmacokinetic (PK) Study
NCT01105780 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of INS1007 in Healthy Japanese and Caucasian Participants
NCT05927597 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Pharmacokinetics and Safety of Alefacept in Caucasian and Japanese Healthy Volunteers
NCT00653822 ·Status: COMPLETED ·Phase: PHASE1
-
A Clinical Study to See How the Study Drug MT-4129 is Taken up by the Body in Healthy Volunteers
NCT02953132 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Healthy Japanese Male Volunteers
NCT00421226 ·Status: COMPLETED ·Phase: PHASE1